Evidence map›Paper›PMID 40687866›Full record

ArticleIndian journal of surgical oncology2025

Primary Mucinous Ovarian Carcinoma: Insight into a Rare Histology and Impact of Pattern of Infiltration on Oncological Outcomes.

Eshwarya Jessy Kaur, Debabrata Barmon, Lopamudra Kakoti, Upasana Baruah, Dimpy Begum, Partha Sarthi Roy, Duncan Khanikar, Mouchumee Bhattacharyya, Shiraj Ahmed, Ratnadeep Sharma

Abstract read
In one paragraph

Article in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eshwarya Jessy KaurDepartment of Obstetrics and Gynaecology, Command Hospital, Lucknow, 226002 India.ORCID 0000-0003-1837-0336
Debabrata BarmonDepartment of Gynaecological Oncology, Dr B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, India.
Lopamudra KakotiDepartment of Oncopathology, Dr B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, India.
Upasana BaruahDepartment of Gynaecological Oncology, Dr B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, India.
Dimpy BegumDepartment of Gynaecological Oncology, Dr B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, India.
Partha Sarthi RoyDepartment of Medical Oncology, Dr B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, India.
Duncan KhanikarDepartment of Medical Oncology, Dr B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, India.
Mouchumee BhattacharyyaDepartment of Radiation Oncology, Dr B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, India.
Shiraj AhmedDepartment of Oncopathology, Dr B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, India.
Ratnadeep SharmaDr B Borooah Cancer Institute, Tata Memorial Hospital, Guwahati, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary mucinous ovarian carcinomas (pMOCs) are a rare subtype of epithelial ovarian cancer which have a unique biological behaviour. These tumours have been divided into patterns of infiltration, namely expansile and infiltrative types, which in turn have prognostic significance. A hospital-based, retrospective analytical cohort study was conducted at a tertiary cancer center in Northeast India, from September 2019 to September 2023. The objectives were to study the impact of pattern of infiltration on oncological outcomes and to prognosticate them. Histology slides of the diagnosed cases were re-examined according to WHO protocol. Overall incidence of pMOC in our study was 3.3% (32/958 patients). Review of histology slides excluded 8 cases. The expansile pattern was seen in 71.9% (

Indexed as

Epithelial ovarian cancerExpansile patternInfiltrative patternOvarian cancer survivalPrimary mucinous ovarian cancer

Identifiers

PMID40687866
PMCPMC12267818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.